AVEO Pharmaceuticals News - AVEO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
AVEO Pharmaceuticals Inc AVEO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0046 -0.55% 0.8244 0.8435 0.8106 0.82 0.829 16:26:00
more quote information »

Recent News

Date Time Source Heading
10/03/201909:12EDGARCurrent Report Filing (8-k)
9/30/201907:00BWAVEO Oncology Announces Initiation of Enrollment in Phase..
9/27/201907:24EDGARCurrent Report Filing (8-k)
9/26/201907:00BWAVEO Oncology to Present at the 2019 Cantor Fitzgerald..
9/23/201907:00BWAVEO Oncology & EUSA Pharma Announce Presentation of Final..
9/17/201917:23EDGARCurrent Report Filing (8-k)
9/12/201916:11EDGARCurrent Report Filing (8-k)
9/10/201909:44EDGARCurrent Report Filing (8-k)
9/10/201906:30BWAVEO Oncology Announces Updated Overall Survival Hazard..
8/27/201917:26EDGARCurrent Report Filing (8-k)
8/08/201916:05EDGARQuarterly Report (10-q)
8/08/201907:06EDGARCurrent Report Filing (8-k)
8/08/201907:00BWAVEO Reports Second Quarter 2019 Financial Results and..
8/01/201906:16EDGARCurrent Report Filing (8-k)
8/01/201906:00BWKyowa Kirin Buys Back Tivozanib Non-Oncology Rights from..
6/14/201908:03EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/13/201917:02EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201917:01EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201917:01EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201916:07EDGARCurrent Report Filing (8-k)
5/31/201917:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/29/201907:00BWAVEO Oncology to Present at the 2019 BIO International..
5/15/201917:00BWAVEO Oncology Announces Presentations at the 2019 ASCO..
5/10/201913:42EDGARAmended Statement of Ownership (sc 13g/a)
5/09/201916:06EDGARQuarterly Report (10-q)
5/09/201907:07EDGARCurrent Report Filing (8-k)
5/09/201907:00BWAVEO Reports First Quarter 2019 Financial Results and..
5/01/201915:13EDGARConfidential Treatment Order (ct Order)
5/01/201907:00BWAVEO Oncology to Participate in the 5th Annual SunTrust..
4/30/201917:06EDGARAmended Annual Report (10-k/a)
4/30/201906:34EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/30/201906:32EDGARProxy Statement (definitive) (def 14a)
4/23/201916:05BWAVEO Oncology Announces $2M Milestone Payment From EUSA..
4/19/201917:12EDGARProxy Statement - Notice of Shareholders Meeting..
4/17/201914:24EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/16/201909:10GLOBEFactors of Influence in 2019, Key Indicators and Opportunity..
4/15/201909:10GLOBEResearch Report Identifies Lincoln National, Zayo Group,..
4/08/201917:23EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:23EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:22EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:22EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:21EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:21EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:21EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:21EDGARStatement of Changes in Beneficial Ownership (4)
4/08/201917:20EDGARStatement of Changes in Beneficial Ownership (4)
4/04/201916:47EDGARCurrent Report Filing (8-k)
4/04/201916:43EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/03/201916:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/03/201916:01BWAVEO Pharmaceuticals, Inc. Announces Proposed Public..
See more news about this stock »


Your Recent History
NASDAQ
AVEO
AVEO Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.